Beurs.nl monitor iconMarkt Monitor
  • AEX -3,49 919,26 -0,38%
  • DE40 -288,91 22.999,15 -1,24%
  • US500^ 0,00 5.664,36 0,00%
  • US30^ 0,00 41.975,60 0,00%
  • EUR/USD 0,00 1,0830 -0,25%
  • WTI 0,00 68,33 0,00%
  • Gold spot -16,22 3.029,71 -0,53%

Corus Terug naar discussie overzicht

Outlook 2005 van ThyssenKrupp

1 Post
| Omlaag ↓
  1. sunnyb0y 14 februari 2005 13:35
    Outlook
    The world economic upswing will continue in 2005. However, the pace of growth in the usa and Asia is expected to slow somewhat. We do not anticipate any radical improvement in the economic situation in the euro zone and Germany. In addition to the geopolitical situation, the main economic risks continue to lie in the development of raw material and energy prices and the euro-dollar exchange rate.

    We expect the following developments on the major markets:

    The boom on the international steel market will continue this year. The key factor will remain the high growth in Chinese demand, though this is expected to slacken slightly. The situation on the raw material markets will therefore remain tight and result in continuing high raw material costs and steel prices. Overall, we anticipate world crude steel production of approximately 1,090 million metric tons in 2005, 5% more than in 2004. In Germany, production is expected to increase to 47 million tons compared with 46.5 million tons in 2004.
    World auto production is forecast to rise to almost 67 million vehicles in 2005. The main source of this 4% growth will be China and the other Asian countries. Car production in Germany will experience model-related growth, but the boom in heavy trucks is expected to abate.
    The expectations for the German mechanical engineering industry are also positive. A 3% production increase appears realistic in 2005. Growth will also continue in the usa, Japan and China, though at a slightly lower rate than in 2004. Demand for machine tools is expected to grow strongly.
    The situation for the German construction industry remains difficult. A marked weakening is expected in the usa. The prospects for the markets in Central and Eastern Europe and Asia remain more favorable.
    If these economic forecasts prove accurate, we expect the encouraging business performance to continue on the whole in the further course of the year. For the full year we plan sales in the magnitude of just over ?41 billion. This figure does not include portfolio changes. In terms of earnings before taxes, excluding the effects of major disposals and restructuring measures, we aim to surpass the very good level of 2003/2004.

    Source: Interim Report 1st quarter 2004/2005, page 17

    *********************************************

    vr gr

    greenspeak
1 Post
|Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beurs.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.104
AB InBev 2 5.531
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 52.047
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 10.825
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 192
Adecco 1 1
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.797
Aedifica 3 925
Aegon 3.258 323.033
AFC Ajax 538 7.088
Affimed NV 2 6.305
ageas 5.844 109.901
Agfa-Gevaert 14 2.062
Ahold 3.538 74.348
Air France - KLM 1.025 35.260
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.049
Alfen 16 25.152
Allfunds Group 4 1.516
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 418
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.826
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 243.722
AMG 971 134.211
AMS 3 73
Amsterdam Commodities 305 6.743
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 494
Antonov 22.632 153.605
Aperam 92 15.044
Apollo Alternative Assets 1 17
Apple 5 384
Arcadis 252 8.798
Arcelor Mittal 2.034 320.931
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.350
Aroundtown SA 1 221
Arrowhead Research 5 9.750
Ascencio 1 28
ASIT biotech 2 697
ASMI 4.108 39.586
ASML 1.766 109.761
ASR Nederland 21 4.507
ATAI Life Sciences 1 7
Atenor Group 1 522
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.825
Axsome Therapeutics 1 177
Azelis Group 1 66
Azerion 7 3.442